Dorphan SA - Company Review
Dorphan SA - Company ReviewSummary
Dorphan SA (Dorphan) is a drug discovery and development company that provides drugs for orphan and rare genetic diseases for children. The company's activities include the identification of compounds that can be further developed to drugs for orphan and rare genetic diseases, preclinical development of the drugs, and out licensing and sale of the drug candidates. Dorphan’s pipeline product includes DO-1, a preclinical chaperone drug candidate for the treatment of GM1-gangliosidosis and mucopolysaccharidosis type IVB. The company develops molecules for restoring the activity of mutated enzymes in mucopolysaccharidoses and lysosomal storage diseases. Dorphan is headquartered in Lausanne, Switzerland.
This comprehensive company report of Dorphan SA provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.